ArticleAdvanced healthcare materials2026
MOF on HOF NanoFilms for Efficient Bacteria Infected Wound Healing.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The increasing severity of antibiotic-resistant bacterial infections necessitates the development of next-generation wound dressings capable of both potent antimicrobial activity and effective tissue repair. Porous organic framework materials possess stable structural connectivity, large specific surface areas, and well-ordered pore architectures, making them promising platforms for applications in infectious wound healing. In this study, metal-organic framework (MOF) and hydrogen-bonded organic framework (HOF) nanofilms (MOF-on-HOF) were successfully integrated onto medical gauze through van der Waals heterojunction interactions, enabling a synergistic cascade effect that enhances both antibacterial activity and wound regeneration. The MOF-on-HOF composite was uniformly loaded on gauze by utilizing the solution processability of HOF and the interfacial film-forming ability of MOF. The resulting MOF-on-HOF dressing rapidly and efficiently eliminated Gram-positive pathogens, thus demonstrating excellent antibacterial efficacy against Staphylococcus aureus (≥99%). Meanwhile, it facilitated hemostasis, scavenges reactive oxygen species (ROS), and accelerates cell migration. In a methicillin-resistant Staphylococcus aureus (MRSA)-infected wound model, treatment with MOF-on-HOF@guaze eradicated bacterial load on the wound surface, hence reduces the expression of pro-inflammatory cytokines, and significantly promotes wound closure, achieving a wound healing rate of 98%. These results highlight the MOF-on-HOF@guaze as a promising platform for managing acutely infected wounds and combating antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.